World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-DDD-16009406
Date of registration: 2016-10-14
Prospective Registration: Yes
Primary sponsor: Shanghai Pulmonary Hospital
Public title: System Construction of Precious Diagnosis and Evaluation for Pulmonary Arterial Hpyertension
Scientific title: System Construction of Precious Diagnosis and Evaluation for Pulmonary Arterial Hpyertension
Date of first enrolment: 2016-11-01
Target sample size: Target condition:0;Difficult condition:0
Recruitment status: Pending
URL:  http://www.chictr.org.cn/showproj.aspx?proj=16005
Study type:  Diagnostic test
Study design:  Diagnostic test for accuracy  
Phase:  Diagnostic New Technique Clincal Study
Countries of recruitment
China
Contacts
Name: Liu jin-ming   
Address:  507 ZhengMin Rd., YangPu district, Shanghai, China
Telephone: +86 13818181063
Email: jinmingliu2007@163.com
Affiliation:  Shanghai Pulmonary Hospital
Name: jiang Rong   
Address:  507 Zhengmin Road, Yangpu District, Shanghai, China
Telephone: +86 13795493921
Email: listening39@163.com
Affiliation:  Shanghai Pulmonary Hospital
Key inclusion & exclusion criteria
Inclusion criteria: Group 1 Pulmonary arterial hypertension
Exclusion criteria: Group 2 Pulmonary hypertension
Group 3 Pulmonary hypertension
Group 4 Pulmonary hypertension
Group 5 Pulmonary hypertension


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Pulmonary arterial hypertension
Intervention(s)
Gold Standard:;Index test:;
Primary Outcome(s)
clinical worsening events;right heart catherization;cardiopulmonary exerise testing;six-minute walking distance;stresss-echocardiography;CTPA;CMR;biomarker;
Secondary Outcome(s)
Nitrite;Bilirubin;high-density lipoprotein cholesterol;8-Isoprostane F2a;8-Isoprostane F2a;Uric acid;growth differentiation Factor-15;C-reactive protein;D-dimer;von Willebtand Factor;ET-1;Troponin;NT-proBNP;SNP genotype;
Secondary ID(s)
Source(s) of Monetary Support
Shanghai shengkang hospital development center
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history